Gene · 81
Papers2,438
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,438
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Differential histone deacetylase inhibitor-induced perturbations of the global proteome landscape in the setting of high-grade serous ovarian cancer. | Proteomics | 2023 | 36193784 | PubTator, text mining | PubMed |
| Extracellular vesicles in Alzheimer's disease: from pathology to therapeutic approaches. | Neural Regen Res | 2023 | 35799503 | PubTator, text mining | PubMed |
| Label-free Quantitative Proteomic Analysis of Ascorbic Acid-induced Differentially Expressed Osteoblast-related Proteins in Dental Pulp Stem Cells from Deciduous and Permanent Teeth. | Curr Stem Cell Res Ther | 2023 | 35762553 | PubTator, text mining | PubMed |
| Focal segmental glomerulosclerosis and proteinuria associated with Myo1E mutations: novel variants and histological phenotype analysis. | Pediatr Nephrol | 2023 | 35723736 | PubTator, text mining | PubMed |
| Expressional and prognostic value of HPCAL1 in cholangiocarcinoma via integrated bioinformatics analyses and experiments. | Cancer Med | 2023 | 35645147 | PubTator, text mining | PubMed |
| A classification of genes involved in normal and delayed male puberty. | Asian J Androl | 2023 | 35532554 | PubTator, text mining | PubMed |
| Point-of-care diagnosis of cervical cancer: potential protein biomarkers in cervicovaginal fluid. | Turk J Biol | 2022 | 37529256 | PubTator, text mining | PubMed |
| New panel of biomarkers to discriminate between amelanotic and melanotic metastatic melanoma. | Front Oncol | 2022 | 36776379 | PubTator, text mining | PubMed |
| The emerging role of exosomes in innate immunity, diagnosis and therapy. | Front Immunol | 2022 | 36726968 | PubTator, text mining | PubMed |
| Identification and validation of endocrine resistance-related and immune-related long non-coding RNA (lncRNA) signatures for predicting endocrinotherapy response and prognosis in breast cancer. | Ann Transl Med | 2022 | 36660659 | PubTator, text mining | PubMed |
| Mutant and non-mutant neoantigen-based cancer vaccines: recent advances and future promises. | Explor Target Antitumor Ther | 2022 | 36654823 | PubTator, text mining | PubMed |
| Polygenic Risk Score and Risk Factors for Preeclampsia and Gestational Hypertension. | J Pers Med | 2022 | 36579561 | PubTator, text mining | PubMed |
| Focal Segmental Glomerulosclerosis Followed by Granuloma and Preceding T-Cell Lymphoma by 46 Months: A Continuation Process or Coincidence. | Cureus | 2022 | 36579279 | PubTator, text mining | PubMed |
| Comparative RNA-Sequencing Analysis Reveals High Complexity and Heterogeneity of Transcriptomic and Immune Profiles in Hepatocellular Carcinoma Tumors of Viral (HBV, HCV) and Non-Viral Etiology. | Medicina (Kaunas) | 2022 | 36557005 | PubTator, text mining | PubMed |
| Conventional Ameloblastoma. A Case Report with Microarray and Bioinformatic Analysis. | Diagnostics (Basel) | 2022 | 36553196 | PubTator, text mining | PubMed |
| Fibroblast growth factor-2 bound to specific dermal fibroblast-derived extracellular vesicles is protected from degradation. | Sci Rep | 2022 | 36550142 | PubTator, text mining | PubMed |
| Mass spectrometry imaging in gynecological cancers: the best is yet to come. | Cancer Cell Int | 2022 | 36536419 | PubTator, text mining | PubMed |
| Novel targets in renal fibrosis based on bioinformatic analysis. | Front Genet | 2022 | 36523757 | PubTator, text mining | PubMed |
| A computational workflow for predicting cancer neo-antigens. | Bioinformation | 2022 | 36518130 | PubTator, text mining | PubMed |
| Clinical and Pathological Heterogeneity in FSGS due to INF2 Mutations. | Kidney Int Rep | 2022 | 36506246 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/81/papers?page=17